Anuh Pharma (ANUHPHR) Stock Overview
Engages in the manufacture and sale of bulk drugs and chemicals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
ANUHPHR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Anuh Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹89.56 |
| 52 Week High | ₹122.85 |
| 52 Week Low | ₹74.25 |
| Beta | 0.18 |
| 1 Month Change | 7.30% |
| 3 Month Change | -6.61% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -19.62% |
Recent News & Updates
Anuh Pharma Limited's (NSE:ANUHPHR) Earnings Are Not Doing Enough For Some Investors
Oct 28
We Think That There Are More Issues For Anuh Pharma (NSE:ANUHPHR) Than Just Sluggish Earnings
Aug 06Recent updates
Anuh Pharma Limited's (NSE:ANUHPHR) Earnings Are Not Doing Enough For Some Investors
Oct 28We Think That There Are More Issues For Anuh Pharma (NSE:ANUHPHR) Than Just Sluggish Earnings
Aug 06Anuh Pharma Limited's (NSE:ANUHPHR) Shares Bounce 26% But Its Business Still Trails The Market
May 31Fewer Investors Than Expected Jumping On Anuh Pharma Limited (NSE:ANUHPHR)
Apr 04Shareholder Returns
| ANUHPHR | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 7.0% | -0.6% | 0.7% |
| 1Y | n/a | -3.0% | 2.3% |
Return vs Industry: Insufficient data to determine how ANUHPHR performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ANUHPHR performed against the Indian Market.
Price Volatility
| ANUHPHR volatility | |
|---|---|
| ANUHPHR Average Weekly Movement | 3.8% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in IN Market | 8.4% |
| 10% least volatile stocks in IN Market | 3.2% |
Stable Share Price: ANUHPHR has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ANUHPHR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1960 | 295 | Ritesh Shah | www.anuhpharma.com |
Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs.
Anuh Pharma Limited Fundamentals Summary
| ANUHPHR fundamental statistics | |
|---|---|
| Market cap | ₹8.94b |
| Earnings (TTM) | ₹461.44m |
| Revenue (TTM) | ₹7.10b |
Is ANUHPHR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ANUHPHR income statement (TTM) | |
|---|---|
| Revenue | ₹7.10b |
| Cost of Revenue | ₹5.54b |
| Gross Profit | ₹1.56b |
| Other Expenses | ₹1.10b |
| Earnings | ₹461.44m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 14, 2025
| Earnings per share (EPS) | 4.60 |
| Gross Margin | 21.96% |
| Net Profit Margin | 6.50% |
| Debt/Equity Ratio | 3.3% |
How did ANUHPHR perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/30 19:57 |
| End of Day Share Price | 2025/10/30 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Anuh Pharma Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kameswari V. S. Chavali | FirstCall Research |